AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 24146170
Drug: Risedronate 35
RxNorm normalized name: risedronate 35 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risedronate 35 mg once weekly with calcium and vitamin D supplementation
Trial: 23343671
Drug: Protein Blend
RxNorm normalized name: Nutritional Supplement Oral Powder for Suspension [IMMUNE SUPPORT PROTEIN BLEND]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protein Blend (PB) - ∼19 g
Trial: 23343671
Drug: Whey Protein
RxNorm normalized name: Whey protein
DrugBank: Whey (DB18685)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whey Protein (WP) - ∼18 g
Trial: 16717293
Drug: Cetuximab (initial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cetuximab (initial dose 400 mg/m2, subsequent weekly doses 250 mg/m2) in combination with cisplatin (100 mg/m2) and fluorouracil (FU) (escalating doses of 600, 800, and 1,000 mg/m2/d)
Trial: 16717293
Drug: Cetuximab (initial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cetuximab (initial dose 400 mg/m2, subsequent weekly doses 250 mg/m2) in combination with carboplatin (AUC 5) and fluorouracil (FU) (escalating doses of 600, 800, and 1,000 mg/m2/d)
Trial: 16717293
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (cetuximab, cisplatin/carboplatin, and FU)
Trial: 11737876
Drug: UVA irradiation
RxNorm normalized name: UVA URSI
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UVA irradiation administered with an air-conditioned sunbed, cumulative UVA dose: 96 J/cm2, two exposures weekly for three weeks
Trial: 9240635
Drug: Helium-Neon laser
RxNorm normalized name: neon
DrugBank: Neon (DB11589)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Helium-Neon laser treatment (632.8 nm wavelength, power 60 mW), applied daily from d-5 to d-1 on five anatomic sites of the oral mucosa.
Trial: 8260235
Drug: Adjuvant chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant chemotherapy with BCNU 80 mg/m2 i.v. every 4 weeks, actinomycin-D 10 micrograms/kg, vincristine 1.0 mg/m2 i.v. every 2 weeks for 6 months
Trial: 3653755
Drug: Rectal distension
RxNorm normalized name: Disperse Blue 106
DrugBank: Disperse Blue 106 (DB14203)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rectal distension during fasting
Trial: 3653755
Drug: Rectal distension
RxNorm normalized name: Disperse Blue 106
DrugBank: Disperse Blue 106 (DB14203)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rectal distension postprandially
Trial: 31668839
Drug: Gemcitabine plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemcitabine plus oxaliplatin (GEMOX) - gemcitabine 1000 mg/m2, oxaliplatin 100 mg/m2 on day 1 every 2 weeks
Trial: 31668839
Drug: Gemcitabine plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemcitabine plus carboplatin (GCb) - gemcitabine 1000 mg/m2 on day 1 and day 8, carboplatin AUC 4.5 mg/mL/min on day 1 every 3 weeks
Trial: 29902447
Drug: Belladonna and
RxNorm normalized name: BELLADONNA AND DERIVATIVES, PLAIN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Belladonna and opiate suppository (16.2/7.5 mg)
Trial: 27067068
Drug: Cognitive-behavioral intervention
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral intervention (N = 88), administered in five weekly 90-min sessions.
Trial: 10534248
Drug: BoNT/B (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BoNT/B (both doses)
Trial: 7092498
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg of DE gamma E intramuscularly (IM) daily for ten days
Trial: 7092498
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg of DE gamma E intramuscularly (IM) daily for ten days
Trial: 7092498
Drug: 3 mg
RxNorm normalized name: boron 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mg of DE gamma E IM daily for ten days
Trial: 20473735
Drug: Valsartan (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valsartan (80 mg once a day)
Trial: 23011378
Drug: Clarithromycin (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clarithromycin (250 mg/day for 3 months) with topical corticosteroid treatment
Trial: 19605972
Drug: First-line drugs
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: First-line drugs (benzodiazepines: lorazepam, diazepam)
Trial: 19605972
Drug: Second-line drugs
RxNorm normalized name: Gallus gallus gizzard lining preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Second-line drugs (phenytoin, fosphenytoin)
Trial: 19605972
Drug: Refractory status
RxNorm normalized name: Statuss Green Reformulated Jan 2012
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Refractory status epilepticus treatments (barbiturates: phenobarbital, pentobarbital, thiopental; valproate; midazolam; propofol; isoflurane)
Trial: 14994883
Drug: Headgear (HG)
RxNorm normalized name: guaifenesin / hydrocodone bitartrate Oral Solution [Hydro-Tussin HG]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Headgear (HG) treatment for 16 months
Trial: 10634841
Drug: 4% amethocaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4% amethocaine gel (Ametop)
Trial: 11352393
Drug: E45 cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: E45 cream (placebo)
Trial: 8204495
Drug: Epidural morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural morphine 80 micrograms/kg
Trial: 8204495
Drug: Epidural morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural morphine 80 micrograms/kg plus butorphanol 40 micrograms/kg
Trial: 28318984
Drug: Medical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical therapy plus neurovascular thrombectomy (Solitaire FR)
Trial: 25486372
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of CBT and Sertraline (COMB)
Trial: 23390005
Drug: Medication management
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication management with pill placebo (PBO)
Trial: 22935042
Drug: Extra protein
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extra protein (33 g whey protein/day)
Trial: 22935042
Drug: Fast-food meal
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fast-food meal (1350 kcal, 41 g protein)
Trial: 17543376
Drug: Sublingual immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual immunotherapy (SLIT) for 18 months
Trial: 11475558
Drug: Serum antibodies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serum antibodies against 38 kDa
Trial: 11475558
Drug: Serum antibodies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serum antibodies against 38 kDa and ACE activity
Trial: 9806257
Drug: 2.5 mg
RxNorm normalized name: biotin 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 mg per day Org OD 14 (tibolone) for 3 months
Trial: 9806257
Drug: Placebo (multi-vitamin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (multi-vitamin pill) for 3 months
Trial: 2529112
Drug: Intra-arterial therapy
RxNorm normalized name: methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intra-arterial therapy (0.2 mg/kg)
Trial: 2529112
Drug: Intra-arterial (0.21
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-arterial (0.21 mg/kg) plus intravenous (0.09 mg/kg) therapy
Trial: 18632013
Drug: Lifestyle interventions
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lifestyle interventions and medication
Trial: 9728851
Drug: Large-dose esmolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Large-dose esmolol (250 microg x kg(‐1) x min(‐1)) with isoflurane
Trial: 9728851
Drug: Alfentanil (effect
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alfentanil (effect site target of 50 ng/mL) with isoflurane
Trial: 9728851
Drug: Alfentanil with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alfentanil with small-dose esmolol (50 microg x kg(‐1) x min(‐1))
Trial: 9728851
Drug: Alfentanil with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alfentanil with large-dose esmolol
Trial: 9419752
Drug: Transdermal estrogen
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal estrogen patch (TE2)
Trial: 9419752
Drug: Transdermal estrogen
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal estrogen patch with added medroxyprogesterone acetate (TE2/MPA)
Trial: 55780
Drug: Oxprenolol (≤320
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxprenolol (≤320 mg/day, increased to 960 mg if inadequate response)
Trial: 55780
Drug: Methyldopa (≤1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methyldopa (≤1 g/day, increased to 3 g if inadequate response)
Trial: 30852482
Drug: Celecoxib 200
RxNorm normalized name: celecoxib 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celecoxib 200 mg, 1 time/day
Trial: 26199710
Drug: Orally administered
RxNorm normalized name: no vaccine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orally administered IV midazolam (0.5 mg/kg for children under 5 years, 0.2 mg/kg for patients over 5 years)
Trial: 26199710
Drug: Commercially prepared
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Commercially prepared midazolam syrup
Trial: 26199710
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups (IV/Oral and syrup)
Trial: 1794157
Drug: Continuous or
RxNorm normalized name: Medicated Pad or Tape
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous or unequal day-night terbutaline dosing (initial bolus doses of 1.47, 2.94, and 4.41 micrograms/kg)
Trial: 18996742
Drug: Sublingual zolpidem
RxNorm normalized name: zolpidem Sublingual Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual zolpidem (10mg)
Trial: 18996742
Drug: Oral zolpidem
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral zolpidem (10mg)
Trial: 16999754
Drug: Postoperative autologous
RxNorm normalized name: Autologous cultured fibroblasts
DrugBank: Azficel-T (DB11051)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postoperative autologous blood re-infusion system 1
Trial: 16999754
Drug: Postoperative autologous
RxNorm normalized name: Autologous cultured fibroblasts
DrugBank: Azficel-T (DB11051)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postoperative autologous blood re-infusion system 2
Trial: 16999754
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no re-infusion)
Trial: 14532838
Drug: Trospium chloride
RxNorm normalized name: Trospium Chloride
DrugBank: Trospium (DB00209)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Trospium chloride (TCl) 10, 15, 20, or 25 mg daily for 21 days
Trial: 10897047
Drug: Sequential regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential regimen of doxorubicin and CMF
Trial: 6378743
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg ISDN (isosorbide dinitrate) acute administration
Trial: 6378743
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg ISDN (isosorbide dinitrate) during long-term treatment
Trial: 6378743
Drug: Control values
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control values during long-term treatment
Trial: 24597620
Drug: Secukinumab 25
RxNorm normalized name: secukinumab 25 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Secukinumab 25 mg, 75 mg, 150 mg, 300 mg
Trial: 24597620
Drug: Secukinumab (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Secukinumab (all dose groups combined)
Trial: 20068568
Drug: Cetuximab 400
RxNorm normalized name: Cetuximab
DrugBank: Cetuximab (DB00002)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Cetuximab 400 mg/m² at first infusion followed by weekly infusions of 250 mg/m² combined with FUFOX (oxaliplatin 50 mg/m², 5-FU 2000 mg/m², and DL-folinic acid 200 mg/m²)
Trial: 15826417
Drug: Tranexamic acid
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tranexamic acid 20 mg/kg on induction
Trial: 6253122
Drug: Indomethacin (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin (2 mg day‐1 kg‐1) given orally for 7 days
Trial: 31902875
Drug: Bevacizumab (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bevacizumab (5 mg/kg administered intravenously four times with an inter-dose interval of 2 weeks)
Trial: 25845867
Drug: 75 mg
RxNorm normalized name: talc 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 mg KAE609 plus 320 mg PPQ
Trial: 25845867
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg KAE609 plus 1,280 mg PPQ
Trial: 25845867
Drug: PPQ alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PPQ alone (320 mg)
Trial: 25845867
Drug: KAE609 alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: KAE609 alone (25 mg)
Trial: 25845867
Drug: KAE609 and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: KAE609 and PPQ combination
Trial: 20963449
Drug: Miglitol (titrated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Miglitol (titrated from 50 mg to 100 mg 3 times daily)
Trial: 19276198
Drug: Intravenous administration
RxNorm normalized name: intravenous administration set
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous administration of 6 mg of nicorandil
Trial: 17113349
Drug: Ramipril (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ramipril (2.5 mg/day)
Trial: 30919899
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of ramipril and telmisartan
Trial: 15017470
Drug: Extended interval
RxNorm normalized name: Minerval
DrugBank: Idroxioleic acid (DB18213)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended interval dosing (EID) of gentamicin
Trial: 15017470
Drug: Conventional interval
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional interval dosing (CID) of gentamicin
Trial: 11199955
Drug: Quetiapine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quetiapine administered concomitantly with phenytoin
Trial: 22212516
Drug: IABP therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IABP therapy
Trial: 31020797
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no IABP therapy)
Trial: 21353104
Drug: Atorvastatin 5
RxNorm normalized name: amlodipine-atorvastatin 5 mg-80 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 5 mg/d
Trial: 19791551
Drug: Mexicor (0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mexicor (0.3 g per day for 3 weeks)
Trial: 19791551
Drug: Conventional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional therapy (Aspirin Cardio, Trental, Prestarium, Arifon)
Trial: 10397685
Drug: 5.1 g/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5.1 g/d n‐3 FA for 6 months
Trial: 6704277
Drug: 1.5 ml
RxNorm normalized name: Humulin 70/30 1.5 ML Pen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 ml glucose-free 0.5% bupivacaine
Trial: 6704277
Drug: 2 ml
RxNorm normalized name: ethanol 2 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 ml glucose-free 0.5% bupivacaine
Trial: 6704277
Drug: 3 ml
RxNorm normalized name: WATER,INHL 3 ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 ml glucose-free 0.5% bupivacaine
Trial: 6704277
Drug: 4 ml
RxNorm normalized name: ethanol 1.4 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 ml glucose-free 0.5% bupivacaine
Trial: 29031513
Drug: Specific cues
RxNorm normalized name: Pacific halibut
DrugBank: Pacific halibut (DB10616)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Specific cues about upcoming hazards (e.g., 'crosswalk ahead')
Trial: 27543530
Drug: Saline group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline group (received ultrasound‐guided saline injection in the ilioinguinal and iliohypogastric nerve region before surgery and ropivacaine after surgery)
Trial: 27543530
Drug: Block group
RxNorm normalized name: Ivy Block
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Block group (received injections in the opposite order: ropivacaine before surgery and saline after surgery)
Trial: 22105837
Drug: Antimicrobial photodynamic
RxNorm normalized name: GAUZE,ANTIMICROBIAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antimicrobial photodynamic therapy (PDT)
Trial: 22105837
Drug: Diode soft
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diode soft laser therapy (DSL)
Trial: 18387426
Drug: Probiotic combination
RxNorm normalized name: PROBIOTIC COMBINATION CAP/TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotic combination (1 x 10(10) cfu once daily) for four weeks
Trial: 16354821
Drug: Azithromycin 1,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azithromycin 1,000 mg q.d. x 3
Trial: 16354821
Drug: Chloroquine 600
RxNorm normalized name: Chloroquine
DrugBank: Chloroquine (DB00608)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chloroquine 600 mg q.d. x 2 then 300 mg on Day 3 followed by primaquine on Days 7 through 20
Trial: 12757214
Drug: Combined albendazole
RxNorm normalized name: Albendazole
DrugBank: Albendazole (DB00518)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Combined albendazole 400 mg and praziquantel 20 mg/kg
Trial: 12757214
Drug: Albendazole 800
RxNorm normalized name: Albendazole
DrugBank: Albendazole (DB00518)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Albendazole 800 mg as a single dose
Trial: 12757214
Drug: Tinidazole 50
RxNorm normalized name: tinidazole 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tinidazole 50 mg/kg as a single dose
Trial: 11212974
Drug: Amlodipine (5-10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine (5-10 mg)
Trial: 7018182
Drug: Peroral estrogen
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peroral estrogen (estradiol valerate), 4 mg daily
Trial: 26803746
Drug: Celecoxib administration
RxNorm normalized name: Celecoxib
DrugBank: Celecoxib (DB00482)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Celecoxib administration immediately after surgery
Trial: 26803746
Drug: No celecoxib
RxNorm normalized name: Celecoxib
DrugBank: Celecoxib (DB00482)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: No celecoxib administration (control)
Trial: 24981241
Drug: Local anesthesia
RxNorm normalized name: Esters of benzoic acid for local anesthesia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local anesthesia with intravenous sedation
Trial: 22502753
Drug: Intracoronary BMNCs
RxNorm normalized name: HELIUM 992 mL in 1 L INTRACORONARY GAS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracoronary BMNCs injection (n=17, BMNCs group)
Trial: 22502753
Drug: Standard therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard therapy (n=10, Control group)
Trial: 17381977
Drug: Fluid Restriction
RxNorm normalized name: amniotic fluid (bovine)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluid Restriction (FR): 193 (sem 19) ml water/d
Trial: 17381977
Drug: Fluid and
RxNorm normalized name: amniotic fluid (bovine)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluid and Energy Restriction (F+ER): Combination of FR and ER
Trial: 17381977
Drug: Control: Estimated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control: Estimated energy (12,154 (sem 230) kJ/d) and water (3912 (sem 140) ml/d) requirements
Trial: 11519769
Drug: Bupropion SR
RxNorm normalized name: Bupropion Hydrochloride 100 MG Oral Tablet, Extended Release, 12 HR [BUPROPION SR]
DrugBank: Bupropion (DB01156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bupropion SR 150 to 400 mg/d
Trial: 11519769
Drug: Fluoxetine 20
RxNorm normalized name: fluoxetine 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine 20 to 60 mg/d
Trial: 8192170
Drug: Fluvastatin (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin (40 mg/d) + Bezafibrate (400 mg/d)
Trial: 8192170
Drug: Fluvastatin (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin (40 mg/d) + Cholestyramine
Trial: 8192170
Drug: Fluvastatin monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin monotherapy (40 mg/d)
Trial: 3130892
Drug: Sodium valproate
RxNorm normalized name: sodium valproate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium valproate (VPA; 500 mg thrice daily for 7 days)
Trial: 30845330
Drug: Vi-typhoid conjugate
RxNorm normalized name: typhoid Vi polysaccharide vaccine, S typhi Ty2 strain
DrugBank: Typhoid Vi polysaccharide vaccine (DB10803)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vi-typhoid conjugate vaccine (Vi-TCV) co-administered with yellow fever vaccine (YFV) at 9 months and meningococcal A conjugate vaccine (MCV-A) at 15 months.
Trial: 24867230
Drug: Clot-SRV (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clot-SRV (50 mg of clotrimazole once a day)
Trial: 24867230
Drug: Clotrimazole troches
RxNorm normalized name: clotrimazole
DrugBank: Clotrimazole (DB00257)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clotrimazole troches (5 troches of 10 mg clotrimazole/day)
Trial: 19738036
Drug: Prednisone (0.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisone (0.8 mg x kg(‐1) x day(‐1))
Trial: 17873675
Drug: Escitalopram 10
RxNorm normalized name: escitalopram 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Escitalopram 10 mg for 12 weeks